One reason for not achieving better results in chronic bacteriuria, even after protracted antimicrobial therapy, may be failure to differentiate two patterns of recurrent infections – namely ...

route of administration and duration of antimicrobial therapy. Core members of the team should include a physician and a clinical pharmacist, both with training in infectious diseases with an ...

AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

In a lecture at VMX, Jason B. Pieper, DVM, MS, DACVD, outlined the next steps in the treatment of pyoderma in dogs when the ...

The following is a summary of “Bacteriophage therapy in women with chronic recurrent cystitis caused by multidrug-resistant bacteria: A prospective, observational, comparative study,” published in the ...

The development of nanodrugs targeting multidrug-resistant bacteria, while sparing the beneficial constituents of the microbiome, has emerged as a promising approach to combat disease and curb the ...

Nat Clin Pract Gastroenterol Hepatol. 2005;2(4):191-198. As antimicrobial resistance increases with more widespread use of these drugs, newer drugs with less potential for the development of ...